IL105347A0 - Multiple sclerosis t-cell receptor - Google Patents

Multiple sclerosis t-cell receptor

Info

Publication number
IL105347A0
IL105347A0 IL105347A IL10534793A IL105347A0 IL 105347 A0 IL105347 A0 IL 105347A0 IL 105347 A IL105347 A IL 105347A IL 10534793 A IL10534793 A IL 10534793A IL 105347 A0 IL105347 A0 IL 105347A0
Authority
IL
Israel
Prior art keywords
multiple sclerosis
cell receptor
amino acids
terminal amino
peptides
Prior art date
Application number
IL105347A
Other languages
English (en)
Original Assignee
Autoimmune Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autoimmune Corp filed Critical Autoimmune Corp
Publication of IL105347A0 publication Critical patent/IL105347A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Rehabilitation Therapy (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL105347A 1992-04-09 1993-04-09 Multiple sclerosis t-cell receptor IL105347A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86531892A 1992-04-09 1992-04-09

Publications (1)

Publication Number Publication Date
IL105347A0 true IL105347A0 (en) 1993-08-18

Family

ID=25345228

Family Applications (1)

Application Number Title Priority Date Filing Date
IL105347A IL105347A0 (en) 1992-04-09 1993-04-09 Multiple sclerosis t-cell receptor

Country Status (15)

Country Link
EP (2) EP0863155B1 (da)
JP (1) JP3434510B2 (da)
KR (1) KR950700934A (da)
AT (2) ATE170874T1 (da)
AU (1) AU680824B2 (da)
BR (1) BR9306272A (da)
CA (1) CA2133749A1 (da)
DE (2) DE69331501T2 (da)
DK (1) DK0863155T3 (da)
ES (1) ES2172044T3 (da)
HU (1) HU219306B (da)
IL (1) IL105347A0 (da)
NO (1) NO317049B1 (da)
PT (1) PT863155E (da)
WO (1) WO1993021222A1 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869054A (en) * 1987-06-24 1999-02-09 Autoimmune Inc. Treatment of multiple sclerosis by oral administration of autoantigens
US6252040B1 (en) * 1991-10-22 2001-06-26 The Governors Of The University Of Alberta Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
US5817629A (en) * 1991-10-22 1998-10-06 The Governors Of The University Of Alberta Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
EP0758902A1 (en) * 1994-05-10 1997-02-26 Immulogic Pharmaceutical Corporation Compositions and treatment for multiple sclerosis
SI9520118A (sl) * 1994-10-25 1998-08-31 Immulogic Pharmaceutical Corporation Sestavki in zdravljenje multiple skleroze
US6251396B1 (en) 1994-11-18 2001-06-26 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
US6379670B1 (en) 1994-11-18 2002-04-30 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
US6329499B1 (en) * 1994-11-18 2001-12-11 Neurocrine Biosciences, Inc. Methods for treatment of multiple sclerosis using peptide analogues of human myelin basic protein
EP1172376A1 (en) * 1994-11-18 2002-01-16 Neurocrine Biosciences, Inc. Peptide analogues at position 91 of human myelin basic protein for treatment of multiple sclerosis
AU5360796A (en) * 1995-03-09 1996-10-02 Neurocrine Biosciences, Inc. Peptide analogues of human myelin basic protein useful in treating multiple sclerosis
US5856446A (en) * 1995-07-07 1999-01-05 Autoimmune Inc. Method of treating rheumatoid arthritis with low dose type II collagen
IL116559A (en) * 1995-11-17 2005-11-20 Yissum Res Dev Co Chimeric protein consisting of a bacterial toxin and a myelin basic protein sequence
US6274136B1 (en) * 1996-05-29 2001-08-14 University Of Southern California Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
CA2494338C (en) * 1997-04-04 2007-07-17 The Governors Of The University Of Alberta Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
US20020072493A1 (en) 1998-05-19 2002-06-13 Yeda Research And Development Co. Ltd. Activated T cells, nervous system-specific antigens and their uses
JP2003532618A (ja) * 1998-05-19 2003-11-05 イエダ リサーチ アンド デベロプメント カンパニイ リミテッド 細胞、神経系−特異的抗原およびそれらの用途
JP4986361B2 (ja) 2000-05-24 2012-07-25 ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ Ｅ−セレクチンに対する寛容誘導による脳卒中防止法
EP1677821B1 (en) 2003-10-17 2013-02-27 Baylor College Of Medicine A method for increasing cd8+ cytotoxic t cell reponses and for treating multiple sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0720622A1 (en) * 1993-09-22 1996-07-10 The Board Of Trustees Of The Leland Stanford Junior University Interaction of t-cell receptors and antigen in autoimmune disease
EP1172376A1 (en) * 1994-11-18 2002-01-16 Neurocrine Biosciences, Inc. Peptide analogues at position 91 of human myelin basic protein for treatment of multiple sclerosis

Also Published As

Publication number Publication date
NO943755L (no) 1994-12-02
WO1993021222A1 (en) 1993-10-28
DE69320967T2 (de) 1999-05-12
DE69331501D1 (de) 2002-03-14
ATE170874T1 (de) 1998-09-15
CA2133749A1 (en) 1993-10-28
JP3434510B2 (ja) 2003-08-11
AU680824B2 (en) 1997-08-14
HU9402909D0 (en) 1995-01-30
PT863155E (pt) 2002-07-31
NO943755D0 (no) 1994-10-06
EP0650498A1 (en) 1995-05-03
DE69331501T2 (de) 2002-08-29
ATE212358T1 (de) 2002-02-15
BR9306272A (pt) 1998-06-23
EP0650498A4 (en) 1995-06-21
DK0863155T3 (da) 2002-05-13
DE69320967D1 (de) 1998-10-15
JPH08500083A (ja) 1996-01-09
ES2172044T3 (es) 2002-09-16
KR950700934A (ko) 1995-02-20
AU4282493A (en) 1993-11-18
EP0863155A1 (en) 1998-09-09
EP0863155B1 (en) 2002-01-23
HU219306B (en) 2001-03-28
NO317049B1 (no) 2004-07-26
EP0650498B1 (en) 1998-09-09
HUT69169A (en) 1995-08-28
KR100295606B1 (da) 2001-10-22

Similar Documents

Publication Publication Date Title
IL105347A0 (en) Multiple sclerosis t-cell receptor
AU5670994A (en) Interleukin-3 (il-3) mutant polypeptides
MX9800418A (es) Analogos de la hormona paratiroidea.
EP1440980A3 (en) Peptide analogs of human myelin basic protein
SG70553A1 (en) T-cell receptor-specific for antigen polypeptides and related polynucleotides
EP0378641A4 (en) Novel antimicrobial peptide, compositions containing same and uses thereof
EP0433509A3 (en) Polypeptides having thyrotropin receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides
ES8801036A1 (es) Un metodo para detectar la presencia de un inhibidor de anticuerpos de factor viii humano en una muestra
GB9606040D0 (en) Active peptide
ES2095255T3 (es) Analogos de sustitucion de peptidos magainina.
DE69120776D1 (de) Neue inhibitorische Peptide
CA2149038A1 (en) Phospholipase C-Inhibiting Peptides